p re ss phospho 4ebp1 s65 (Proteintech)
Proteintech is a verified supplier 
94
Structured Review
Proteintech
p re ss phospho 4ebp1 s65
P Re Ss Phospho 4ebp1 S65, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+4ebp1/4EBP1+Fusion+Protein/pm41904147-229-100-127
Average 94 stars, based on 18 article reviews
P Re Ss Phospho 4ebp1 S65, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+4ebp1/4EBP1+Fusion+Protein/pm41904147-229-100-127
Average 94 stars, based on 18 article reviews
p re ss phospho 4ebp1 s65 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: Translation-specific disruption of Col1a1 expression in multiple models of Spinal Muscular Atrophy can be rescued by Risdiplam Article Snippet: Primary antibodies: Cell Signaling 4858S: p-RPS6 (1: 1000 - 1:2000), Abcam ab2606: 4EBP1 (1: 1000 - 1:2000), Abcam ab27792: p-4EBP1 (1: 1000 - 1:2000), Article Title: MEK inhibitor trametinib combined with PI3K/mTOR inhibitor BEZ-235 as an effective strategy against NSCLC through impairment of glucose metabolism. Article Snippet: The MAPK and PI3K/AKT/mTOR pathways are aberrantly activated in non-small cell lung cancer (NSCLC) patients, but therapeutic efficacy of NSCLC using trametinib (MEK inhibitor) or BEZ-235 (dual PI3K/mTOR inhibitor) alone is still unsatisfactory.. Therefore, in this study, we aimed to determine whether the combination of trametinib with BEZ-235 exerted synergistic effects against NSCLC in both in vitro and in vivo models, and we preliminarily explored the effect of this combination therapy on glucose metabolism.. Our results showed that trametinib combined with BEZ-235 could better inhibit cell proliferation and colony formation, induce G0/G1 phase arrest and apoptosis, and suppress cell invasion and migration compared with the single agent. Article Title: Dietary phosphatidylcholine supplementation modulates muscle quality attributes in blunt snout bream (Megalobrama amblycephala): A focus on texture, water-holding capacity, color, collagen properties, and nutritional value. Article Snippet: Phosphatidylcholine (PC) is a potential modulator for fish muscle quality, but its comprehensive effects remain unclear.. In this study, the effects of PC supplementation on fish quality were investigated systematically.. This study examined the impact of dietary PC supplementation (0 %, 0.25 %, 0.50 %, 0.75 %, and 1.00 %) on the muscle quality of fish. Membrane:Article Title: Exosomes from systemic lupus erythematosus (SLE) patients facilitate the production of inflammatory cytokines in dendritic cells (DCs) by regulating the mTOR signaling. Article Snippet: .. Incubation:Article Title: Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171. Article Snippet: Despite the recent development of PIM inhibitors based on N-(pyridin-3-yl)acetamide scaffold for acute myeloid leukemia (AML), the structural-activity relationship (SAR) associated with the effects of positional isomerization of N toward to Lys67 and freedom of solvent fragment toward to Asp128/Glu171 still remains an open question.. In this work, a structurally novel compound based on N-pyridinyl amide was designed by fragment hybridization and then our SAR exploration revealed that the positional isomerization would lead to a decrease in activity, while increase of the freedom of solvent fragment by breaking the intramolecular hydrogen bond unprecedentedly leads to an increase in activity.. These studies finally resulted in the screening out of a potent PIM inhibitor FD1024 (compound 24) which exerts strong antiproliferative activity against the tested AML cell lines and achieves profound antitumor efficacy in mice at well-tolerated dose schedules. |